Mother's Antibiotics - Doubles Child Obesity
Background/Objectives: Cesarean section (CS) and Antibiotic
use during pregnancy may alter normal maternal-fetal microbiota exchange, thereby contributing to aberrant microbial colonization of the infant gut and increased susceptibility to obesity later in life. We hypothesized that i) maternal use of Antibiotics
in the second or third trimester of pregnancy and ii) CS are independently associated with higher risk of childhood obesity in the offspring.
Subjects/Methods: Of the 727 mothers enrolled in the Northern Manhattan Mothers and Children Study, we analyzed the 436 mother-child dyads followed until 7 years of age with complete data. We ascertained prenatal Antibiotic
by a questionnaire administered late in the third trimester, and delivery mode by medical record. We derived age- and sex-specific BMI z scores using the CDC SAS Macro, and defined obesity as BMI z≥95th percentile. We used binary regression with robust variance and linear regression models adjusted for maternal age, ethnicity, pre-gravid BMI, maternal receipt of public assistance, birth weight, sex, breast feeding in the first year, and gestational Antibiotics
or delivery mode.
Results: Compared to children not exposed to Antibiotics
during the second or third trimester, those exposed had 84% (33-154%) higher risk of obesity, after multivariable adjustment. Second or third trimester Antibiotic
exposure was also positively associated with BMI z scores, waist circumference, and % body fat (all P<0.05). Independent of prenatal antibiotic usage, CS was associated with 46% (8-98%) higher offspring risk of childhood obesity. Associations were similar for elective and non-elective CS.
Conclusions: In our cohort, CS and exposure to antibiotics in the second or third trimester were associated with higher offspring risk of childhood obesity. Future studies that address the limitations of our study are warranted to determine if prenatal antibiotic use is associated with offspring obesity. Research is also needed to determine if alterations in neonatal gut microbiota underlie the observed associations.